v3 Template
H
Hangzhou Diagens Biotechnology Co., Ltd.
Biotechnology and Healthcare
Founded
--
Employees
--
Total Funding
$101.0M
Funding Rounds
1
Last Funding
2026-03-31
About Hangzhou Diagens Biotechnology Co., Ltd.
Hangzhou Diagens Biotechnology Co., Ltd. is a company focused on intelligent medical device products and AI-driven health solutions, aiming to advance medical diagnostics and research through innovative technology in cytogenetics and medical imaging.
Products & Services
AIAutoVision(r) Chromosome Karyotype Assisted Diagnosis System:An AI-powered system for assisting in chromosome karyotype diagnosis.
MetaSight(r) Automatic Cell Microscopic Image Scanning System:An automated system for scanning microscopic cell images.
KayoFlow(r) Cytogenetics Automatic Cell Harvester:An automated cell harvester for cytogenetics applications.
KayoFlow(r) Integrated Slide Preparation and Staining System:A system for preparing and staining slides in cytogenetics workflows.
KayoFlow(r) Workflow:A comprehensive workflow solution for cytogenetics processes.
Cytogenetics Laboratory Reagents and Consumables:Reagents and consumables for cytogenetics laboratories.
Integrated Storage, Computation, Training and Inference Localized Solution:A localized solution for storage, computation, training, and inference in medical applications.
iMed MaaS Medical Imaging AI Platform:An AI platform for medical imaging services.
AI-Driven Genetics Health Solutions:AI-based solutions for genetics health applications.
iMedImage(r) Based Model Service Portfolio:A portfolio of model services based on iMedImage technology for research purposes.
Specialties
AI-Driven Medical Diagnostics
Cytogenetics
Medical Imaging
Chromosome Karyotype Analysis
Genetics Health Solutions
Radiological Health Solutions
Hematology Solutions
Funding History
Debug: View Raw Funding Data
| # | Type | Amount Fields | Date Fields | Investors |
|---|---|---|---|---|
| 1 |
RT: IPO T: - FT: IPO |
A: 101000000 MR: - FA: US$101 million FAN: 101000000 |
D: 2026-03-31 FD: 2026-03-31 |
- |
IPO
Latest
2026-03-31
$101.0M
Growth Metrics
+45%
Employee Growth
YoY
3.2x
Funding Growth
Last Round
12
Markets
Operating
10K+
Customers
Active
Mock Up
Team & Leadership
No team data available
Team information is not yet available for this company
Recent News
Hangzhou Diagens Biotechnology Co., Ltd. Announces New Product Launch
2 days agoCompany unveils innovative solution to transform the industry, expanding market reach and capabilities...
Read more →Leadership Team Expands with Industry Veteran
1 week agoNew executive brings 20+ years of experience to accelerate growth and strategic initiatives...
Read more →Company Recognized as Industry Leader
2 weeks agoReceives prestigious award for innovation and customer satisfaction in competitive market...
Read more →Mock Up
Key Competitors
C1
Competitor Alpha
Series B · $50M raised
C2
Competitor Beta
Series C · $120M raised
C3
Competitor Gamma
Series A · $25M raised
C4
Competitor Delta
Seed · $10M raised
Mock Up
Company Details
- Website
- diagens.com
- Industries
- Biotechnology and Healthcare
Similar Companies
Discover AI-powered company recommendations based on industry, funding, and team profiles.
Upgrade to ProTechnology Stack
Discover the backend, frontend, and infrastructure technologies powering this company's products.
Upgrade to Pro